Reactome: A Curated Pathway Database
The EBI data centre will be shutting down from the afternoon (BST) of Friday 26th August until the afternoon of Tuesday 30th August 2016 for essential maintenance. This might have an impact on some Reactome services and we apologize for any inconvenience.

Hypophosphorylation of RNA Pol II CTD by FCP1P protein

Stable Identifier
Homo sapiens
Locations in the PathwayBrowser

FCP1 dephosphorylates RNAP II in ternary elongation complexes as well as in solution and is thought to function in the recycling of RNAP II during the transcription cycle. Biochemical experiments suggest that human FCP1 targets CTDs that are phosphorylated at serine 2 (CTD-serine 2) and/or CTD-serine 5. It is also observed to stimulate elongation independent of its catalytic activity. Dephosphorylation of Ser2 - phosphorylated Pol II results in hypophosphorylated form that disengages capping enzymes (CE).

Literature References
Participant Of
This entity is regulated by:
Title Physical Entity Activity
phosphoprotein phosphatase activity of CTDP1 [nucleoplasm] CTDP1 [nucleoplasm] phosphoprotein phosphatase activity (0004721)
Orthologous Events